£1.0M
The seed round features backing from Saul Milton and Mark Wilkinson to support European expansion.
"Since medicinal cannabis was legalised five years ago, patients have continued to struggle to obtain quality products through the legal market. Not only is the calibre often very hit and miss, there are also only a handful of strains to choose from; which don’t suit everyone. However, access to this medication is life changing and essential to over a million people in the UK today. By opening equity and a seat at the table to the community, GLO is truly democratising a space that was unreachable for many."